Secure your spot at the 2022 Policy Summit, Sept. 26-27 in Washington, D.C. (limited space) or virtually!
The latest research & insights on cutting-edge topics chosen by ASGCT committees and presented by gene and cell therapy experts.
This session highlights the ongoing research related to the administration of high-dose adeno-associated virus (AAV) in patients with an emphasis on safety and tolerability findings.
ASGCT Members and registrants can watch it on demand now!
Watch On Demand
Speakers will discuss cutting-edge concepts and methods in the design and development of AAV vectors.
Each session is free for ASGCT members and $50 for non-members.
American PIs will learn about the importance of bringing international trainees to their labs. Early career investigators will share their experiences in transitioning to working for U.S.-based academic institutions. Attendees will learn best practices around finding employment and hiring non-U.S. based PhD students and postdoctoral fellows to the U.S.
This session seeks to provide a better understanding of long COVID-19, which affects about 10% of patients who become infected with SARS-CoV-2. Speakers will discuss the pathogenesis, clinical aspects, and immune responses, of COVID-19 and long COVID.
September 26-27, 2022
© 2000-2022 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico